Actinium-225 as an example for monitoring of internal exposure of occupational intakes of radionuclides in face of new nuclear-medical applications for short-lived alpha emitting particles
Radiation and Environmental Biophysics · 2024
DOI: 10.1007/s00411-024-01081-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation and Environmental Biophysics, 2024. Verfasst von Sven Hartmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Federal Office for Radiation Protection, Medical and Occupational Radiation Protection, Incorporation Monitoring MB 5, Berlin, Germany. shartmann@bfs…. Hauptthemen laut MEDLINE: Occupational Exposure, Alpha Particles, Radiation Monitoring, Actinium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesamt für Strahlenschutz.
Abstract (Originalsprache)
Monitoring of internal exposure to short-lived alpha-emitting radionuclides such as actinium-225 ( 225 Ac), which are becoming increasingly important in nuclear medicine, plays an important role in the radiation protection of occupationally exposed persons. After having tested gamma spectrometry, liquid scintillation counting and alpha spectrometry for monitoring of internal exposure, the focus of the present study was on solid phase extraction of 225 Ac from urine in combination with alpha spectrometry. The development of the method was based on recent findings from the literature on this topic. The method was used in a pilot phase to monitor internal exposure of four workers who were directly or indirectly involved in the manufacture and/or use of 225 Ac. The monitoring protocol allowed a relatively short 24-hour urine sample analysis with excellent recovery of the internal standard, but it did not allow for a detection limit of less than 1 mBq nor a sufficient yield of 225 Ac. Based on these results it is concluded that an in vitro excretion analysis alone is not appropriate for monitoring internal exposure to 225 Ac. Instead, different radiation monitoring techniques have to be combined to ensure the radiation protection of employees.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Federal Office for Radiation Protection, Medical and Occupational Radiation Protection, Incorporation Monitoring MB 5, Berlin, Germany. shartmann@bfs.de.
- Federal Office for Radiation Protection, Medical and Occupational Radiation Protection, Incorporation Monitoring MB 5, Berlin, Germany.
- Federal Office for Radiation Protection, Environmental Radioactivity, Dosimetry and Spectrometry UR 5, Berlin, Germany.
- ITM Medical Isotopes GmbH, Munich, Germany.
ORCID-Profile: Sven Hartmann, Oliver Meisenberg
Förderung
- Bundesamt für Strahlenschutz
Zitieren
APA
Hartmann, S., Taubner, K., Vogt, T., Meisenberg, O., Schkade, U. K., Steyer, C., Meckel, M., & Kesenheimer, C. (2024). Actinium-225 as an example for monitoring of internal exposure of occupational intakes of radionuclides in face of new nuclear-medical applications for short-lived alpha emitting particles. Radiation and Environmental Biophysics. https://doi.org/10.1007/s00411-024-01081-4
Vancouver
Hartmann S, Taubner K, Vogt T, Meisenberg O, Schkade UK, Steyer C, et al. Actinium-225 as an example for monitoring of internal exposure of occupational intakes of radionuclides in face of new nuclear-medical applications for short-lived alpha emitting particles. Radiation and Environmental Biophysics. 2024. doi:10.1007/s00411-024-01081-4
BibTeX
@article{Hartmann2024,
author = {Hartmann, Sven and Taubner, Kerstin and Vogt, Tobias and Meisenberg, Oliver and Schkade, Uwe-Karsten and Steyer, Christian and Meckel, Marian and Kesenheimer, Christian},
title = {Actinium-225 as an example for monitoring of internal exposure of occupational intakes of radionuclides in face of new nuclear-medical applications for short-lived alpha emitting particles},
journal = {Radiation and Environmental Biophysics},
year = {2024},
doi = {10.1007/s00411-024-01081-4}
}
EUVIMED